Sandoz To Invest New Biosimilar Facility In Slovenia
(RTTNews) - Sandoz Group AG (SDZ.SW, SDZNY) on Tuesday said it plans to invest around $300 million to build a new biosimilar manufacturing facility in Ljubljana, Slovenia.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.